Johnson & Johnson's booster shot provides high levels of protection against the omicron variant of Covid-19, according to data from a trial of healthcare workers in South Africa released Thursday.
Preliminary results from the Sisonke study, which have not been peer-reviewed, found that for people who had received one vaccine dose, the booster improved protection against hospitalization to 85 percent from 63 percent.
Problem, Solution, SitRep, or ?:
Recent Comments